日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preventing trogocytosis by cathepsin B inhibition augments CAR T-cell function

通过抑制组织蛋白酶B来阻止细胞吞噬作用可增强CAR T细胞功能。

Dietze, Kenneth A; Nguyen, Kiet; Pathni, Aashli; Fazekas, Frank; Sun, Wenxiang; Rosati, Ethan; Baker, Jillian M; Galeana Figueroa, Maday; Gebru, Etse; Yamoah, Daniel; Mulatu, Rediet; Wang, Alexander; Rapoport, Aaron P; Lum, David H; Fan, Xiaoxuan; Radhakrishnan, Sabarinath V; Atanackovic, Djordje; Upadhyaya, Arpita; Luetkens, Tim

CNS infiltration by zamtocabtagene autoleucel tandem CD20/CD19 CAR T cells leading to complete remission in a patient with primary CNS lymphoma

zamtocabtagene autoleucel tandem CD20/CD19 CAR T 细胞浸润中枢神经系统,导致原发性中枢神经系统淋巴瘤患者完全缓解

Hardy, Nancy M; Yared, Jean A; Luetkens, Tim; Ahmad, Haroon; Mulatu, Rediet; Yamoah, Daniel; Fan, Xiaoxuan; Weeks, Samuel; Bredar, Sophia A; Gelin, Ashley; Baker, Jillian M; Dietze, Kenneth A; Matsangos, Aerielle; Fromowitz, Ariel; Theruvath, Johanna; Wirthlin, Louisa; Kaleta, Remigiusz; Wijatyk, Anna; Koka, Rima; Kallen, Michael E; Hankey, Kim G; Rapoport, Aaron P; Atanackovic, Djordje

Faecal microbiota transplant for chronic norovirus infection: a case report of donor microbiota engraftment without clinical success

粪便微生物移植治疗慢性诺如病毒感染:一例供体微生物移植成功但临床疗效不佳的病例报告

Schotz, Kaitlin M; Alizadeh, Madeline; Rapoport, Aaron P; Ravel, Jacques; Von Rosenvinge, Erik C

Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene autoleucel in a real-world cohort of patients with multiple myeloma

在真实世界多发性骨髓瘤患者队列中,抗BCMA CAR-T产品idecabtagene vicleucel和ciltacabtagene autoleucel的免疫相关性

Atanackovic, Djordje; Luetkens, Tim; Schneider, Dina; Hu, Peirong; Wang, Xu; Shetty, Amol C; Tallon, Luke; Patel, Imari; Singh, Rohan; Gebru, Etse; Mulatu, Rediet; Omili, Destiny; Yamoah, Daniel; Fan, Xiaoxuan; Matsangos, Aerielle; Lesho, Patricia; Dietze, Kenneth A; Fromowitz, Ariel A; Hankey, Kim G; Dahiya, Saurabh; Yared, Jean A; Hardy, Nancy M; Koka, Rima; Kallen, Michael E; Badros, Ashraf; Rapoport, Aaron P; Kocoglu, Mehmet H

Successful treatment of refractory cold agglutinin syndrome using fixed-duration daratumumab, bortezomib and dexamethasone with a sutimlimab bridge

使用固定疗程的达雷妥尤单抗、硼替佐米和地塞米松联合舒替利单抗桥接治疗,成功治愈难治性冷凝集素综合征。

Rybinski, Brad; James, Miranda; Hardy, Nancy; Koka, Rima; Rapoport, Aaron P

A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL

一项多中心 I/II 期临床试验,研究来那度胺联合剂量调整的 EPOCH-R 方案治疗 MYC 相关弥漫性大 B 细胞淋巴瘤的疗效。

Cahill, Kirk; Godfrey, James; Nabhan, Chadi; Kline, Justin; Riedell, Peter A; Cohen, Kenneth S; Narula, Sunil; Karrison, Theodore G; Robertson, Jessica; Karmali, Reem; Venugopal, Parameswaran; Kim, Seo-Hyun; Rapoport, Aaron P; Lee, Seung Tae; Law, Jennie; Fishkin, Paul A S; Isufi, Iris; Velasco, Mario; Kaminer, Lynne; Smith, Sonali M

Defibrotide for Protecting Against and Managing Endothelial Injury in Hematologic Malignancies and COVID-19

地夫布罗肽用于预防和治疗血液系统恶性肿瘤和 COVID-19 引起的内皮损伤

Richardson, Edward; Mo, Clifton C; Calabretta, Eleonora; Corrado, Francesco; Kocoglu, Mehmet H; Baron, Rebecca M; Connors, Jean Marie; Iacobelli, Massimo; Wei, Lee-Jen; Benjamin, Emily J; Rapoport, Aaron P; Díaz-Ricart, Maribel; Martínez-Mellado, Antonio José; Carlo-Stella, Carmelo; Richardson, Paul G; Moraleda, José M

Outpatient axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma: ZUMA-24 primary analysis

门诊使用axicabtagene ciloleucel治疗复发/难治性大B细胞淋巴瘤:ZUMA-24初步分析

Leslie, Lori A; Baird, John H; Flinn, Ian W; Tees, Michael; Hoda, Daanish; Deol, Abhinav; Young, Patricia; McClune, Brian; Varadarajan, Indumathy; Essell, James; Fanning, Suzanne; Simmons, Gary; Clark, William; Rapoport, Aaron P; Rodriguez, Tulio E; Winters, Joshua N; Davis, Madison; Miao, Harry M; Ray, Markqayne; Fang, Xiang; Kim, Jenny J; Oluwole, Olalekan O

Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

大B细胞淋巴瘤标准治疗方案Axicabtagene Ciloleucel的五年随访:来自美国淋巴瘤CAR-T细胞治疗联盟的结果

Jain, Michael D; Spiegel, Jay Y; Nastoupil, Loretta J; Tamaresis, John; Ghobadi, Armin; Lin, Yi; Lekakis, Lazaros; Reagan, Patrick; Oluwole, Olalekan; McGuirk, Joseph; Deol, Abhinav; Dorritie, Kathleen A; Sehgal, Alison R; Goy, Andre; Hill, Brian T; Andreadis, Charalambos; Munoz, Javier; Ulrickson, Matthew; Westin, Jason; Chavez, Julio C; Patel, Dilan; Jacobs, Miriam T; Bansal, Radhika; Bennani, N Nora; Patel, Vivek G; Rapoport, Aaron P; Vose, Julie M; Miklos, David B; Neelapu, Sattva S; Locke, Frederick L; Lunning, Matthew; Dahiya, Saurabh

Correction: Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401

更正:树突状细胞/骨髓瘤融合疫苗联合来那度胺维持治疗多发性骨髓瘤一线自体造血干细胞移植后的随机II期试验:BMT CTN 1401

Chung, David J; Shah, Nina; Wu, Juan; Logan, Brent; Bisharat, Lina; Callander, Natalie; Cheloni, Giulia; Anderson, Kenneth; Chodon, Thinle; Dhakal, Binod; Devine, Steve; Dutt, Poorvi Somaiya; Efebera, Yvonne; Geller, Nancy; Ghiasuddin, Haider; Hematti, Peiman; Holmberg, Leona; Howard, Alan; Johnson, Bryon; Karagkouni, Dimitra; Lazarus, Hillard M; Malek, Ehsan; McCarthy, Philip; McKenna, David; Mendizabal, Adam; Nooka, Ajay; Munshi, Nikhil; O'Donnell, Lynn; Patel, Krina; Rapoport, Aaron P; Reese, Jane; Rosenblatt, Jacalyn; Soiffer, Robert; Stroopinsky, Dina; Uhl, Lynne; Vlachos, Ioannis S; Waller, Edmund K; Young, James W; Pasquini, Marcelo C; Avigan, David